NASDAQ · PCVX
Vaxcyte, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PCVX: Nov 3, 2026
Vaxcyte, Inc. Common Stock is estimated to report earnings on 11/03/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-1.84. The reported EPS for the same quarter last year was $-1.56.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-1.84 | $-1.67 | $-2.00 | 2 |
| Dec 2026 | $-1.83 | $-1.83 | $-1.83 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · BNK Invest · Barchart- Zacks · Oct 30, 8:55 AM EDTWall Street Analysts See an 87.35% Upside in Vaxcyte (PCVX): Can the Stock Really Move This High?The mean of analysts' price targets for Vaxcyte (PCVX) points to an 87.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- RTTNews · Oct 16, 5:02 AM EDTShow Me The Money: Vaxcyte Delivers 100%+ Gains As Pneumococcal Vaccine Program Advances(RTTNews) – 2026 has been a breakout year for Vaxcyte Inc. (PCVX), with a string of positive pipeline developments lending its shares fresh momentum.
- Zacks · Oct 14, 8:55 AM EDTWall Street Analysts Think Vaxcyte (PCVX) Could Surge 75.6%: Read This Before Placing a BetThe average of price targets set by Wall Street analysts indicates a potential upside of 75.6% in Vaxcyte (PCVX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- BNK Invest · Oct 12, 10:37 AM EDTInteresting PCVX Put And Call Options For July 2027Investors in Vaxcyte Inc (Symbol: PCVX) saw new options begin trading today, for the July 2027 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 277 days until expiration the newly trading contracts rep
- RTTNews · Oct 9, 1:37 PM EDTWeekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data(RTTNews) – This week, biopharmaceutical companies saw a busy week of regulatory decisions, strategic partnerships and clinical developments, alongside pipeline setbacks and workforce reductions.
- Barchart · Oct 7, 1:04 PM EDTStocks Finish Higher on Lower Bond Yields and Earnings OptimismThe S&P 500 Index ($SPX ) (SPY ) closed up by +0.58% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.48%. December E-mini S&P futures (ESZ26 ) rose +0.61%, and December E-mini…
- RTTNews · Oct 7, 2:58 AM EDTVaxcyte Prices Offerings Of Stock, Warrants, Convertible Notes To Raise Approx. $1 Bln(RTTNews) – Vaxcyte, Inc. (PCVX), a clinical-stage vaccine innovation company, announced late Tuesday the pricing of public offerings of common stock, pre-funded warrants and convertible senior notes for total proceeds of approximately $1.0 billion.
- RTTNews · Oct 7, 2:28 AM EDTVaxcyte Prices $1 Bln In Concurrent Equity, Convertible Notes Offerings(RTTNews) – Vaxcyte, Inc. (PCVX), a clinical-stage vaccine company, announced the pricing of 7.41 million shares of common stock and pre-funded warrants to purchase 0.4 million shares, and $500 million in aggregate principal amount of 1.50% convertible senior notes due 2032.
- Barchart · Oct 6, 7:14 PM EDTS&P 500 and Nasdaq 100 Post Record Highs as Crude Prices and Bond Yields FallThe S&P 500 Index ($SPX ) (SPY ) is up by +0.49% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. December E-mini S&P futures (ESZ26 ) are up +0.54%, and December E-mini…
- Barchart · Oct 6, 6:56 PM EDTStocks Climb as Inflation Risks Ease and Bond Yields DeclineThe S&P 500 Index ($SPX ) (SPY ) is up by +0.75% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.53%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.83%. December E-mini S&P futures (ESZ26 ) are up +0.78%, and December E-mini…
- BNK Invest · Oct 6, 11:32 AM EDTInteresting PCVX Put And Call Options For July 2028Investors in Vaxcyte Inc (Symbol: PCVX) saw new options become available today, for the July 2028 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 654 days until expiration the newly available contract
- RTTNews · Oct 6, 3:37 AM EDTBiotech Stocks At 52-Week Highs – PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5%(RTTNews) – The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Vaxcyte, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.